1st Quarter - Termination
THE NICKLES GROUP, LLC for GILEAD SCIENCES, INC.
Client
Income
$50,000
Expenses
—
Terminated
Mar 31, 2022
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Monitored issues related to the reimbursement of CAR-T cell therapy. Monitored H.R. 5376, the Build Back Better Act, as it relates to drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Government Issues GOV
Monitored issues related to the reimbursement of CAR-T cell therapy. Monitored H.R. 5376, the Build Back Better Act, as it relates to drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.